GlassScriptPhysician profile
Rizwan Danish
NPI 1720076284
$43,483.33
in general payments reported to CMS, 2019-2025
100 companies · $7,260 in 2025
The $7,260 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,057 · 2020: $4,701 · 2021: $6,170 · 2022: $6,145 · 2023: $6,346 · 2024: $7,805 · 2025: $7,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Long Term Medical Supply Or Device Loan: $1,799 · Consulting Fee: $650 · Education: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,325.85 |
| Long Term Medical Supply Or Device Loan | $1,799.04 |
| Consulting Fee | $650.00 |
| Education | $636.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $6,195.57 | 2019-2025 | Kisqali |
| Genentech USA, INC. | $2,015.83 | 2019-2025 | Tecentriq, Venclexta, Polivy |
| Janssen Biotech, INC. | $1,922.46 | 2019-2025 | Darzalex, Tecvayli, Erleada |
| Astrazeneca Pharmaceuticals LP | $1,779.15 | 2019-2025 | Calquence, Lynparza, Tagrisso |
| Merck Sharp & Dohme LLC | $1,610.95 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $1,384.55 | 2019-2025 | |
| Coherus Oncology, INC. | $1,251.40 | 2020-2024 | |
| Eisai INC. | $1,220.00 | 2019-2025 | |
| Amgen INC. | $1,218.17 | 2019-2025 | Imdelltra (Amg757), Lumakras, Vectibix |
| Astellas Pharma US INC | $1,155.89 | 2019-2025 | Xospata, Xtandi, Padcev |
| Genzyme Corporation | $1,089.42 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,032.21 | 2019-2025 | Ojjaara, Zejula, Jemperli |
| Regeneron Healthcare Solutions, INC. | $1,024.20 | 2019-2025 | Libtayo |
| Beigene USA, INC. | $998.78 | 2020-2025 | Brukinsa, Tevimbra |
| Partner Therapeutics, INC. | $900.00 | 2019 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $852.84 | 2019-2025 | Jakafi, Pemazyre, Monjuvi |
| E.R. Squibb & Sons, L.L.C. | $817.67 | 2019-2025 | Opdualag, Opdivo, Abilify |
| Karyopharm Therapeutics INC. | $776.08 | 2020-2025 | Xpovio |
| Takeda Pharmaceuticals U.S.A., INC. | $749.30 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Celgene Corporation | $737.00 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Abbvie INC. | $728.74 | 2019-2025 | Venclexta |
| Lilly USA, LLC | $704.96 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Emd Serono, INC. | $617.10 | 2019-2025 | Bavencio, Tepmetko |
| Seagen INC. | $598.56 | 2019-2023 | Padcev, Tukysa, Tivdak |
| Daiichi Sankyo INC. | $591.90 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Ipsen Biopharmaceuticals, INC | $492.92 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Exelixis INC. | $460.13 | 2019-2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $448.87 | 2019-2025 | Zepzelca |
| Rigel Pharmaceuticals, INC. | $432.27 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Puma Biotechnology, INC. | $366.04 | 2019-2025 | Nerlynx |
| Pharmacyclics LLC, An Abbvie Company | $362.44 | 2019-2023 | Epkinly, Imbruvica |
| Alexion Pharmaceuticals, INC. | $358.81 | 2019-2025 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $350.75 | 2019-2025 | |
| Array Biopharma INC | $313.10 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Legend Biotech USA INC. | $308.23 | 2024-2025 | Carvykti |
| Gilead Sciences, INC. | $295.63 | 2019-2025 | Trodelvy |
| Tempus Ai, INC | $278.76 | 2024-2025 | Xt Cdx |
| Sobi, INC | $277.43 | 2022-2025 | |
| Aveo Pharmaceuticals, INC. | $264.66 | 2021-2025 | Fotivda |
| Pharmaessentia USA Corporation | $259.20 | 2022-2025 | Besremi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $255.71 | 2019-2025 | Gilotrif |
| Acrotech Biopharma INC. | $255.43 | 2022-2025 | Beleodaq |
| Amag Pharmaceuticals, INC. | $252.26 | 2019-2022 | |
| Taiho Oncology, INC. | $233.74 | 2019-2024 | |
| Deciphera Pharmaceuticals INC. | $220.23 | 2021-2025 | Qinlock |
| Apellis Pharmaceuticals, INC. | $219.72 | 2022-2025 | Empaveli |
| Dendreon Pharmaceuticals LLC | $219.72 | 2022-2024 | Provenge |
| Octapharma USA, INC. | $219.19 | 2019-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Pharmacosmos Therapeutics INC. | $218.76 | 2021-2025 | Monoferric |
| Blueprint Medicines Corporation | $217.13 | 2020-2025 | Ayvakit |
| Stemline Therapeutics INC. | $179.32 | 2023-2025 | Orserdu |
| Dova Pharmaceuticals | $175.61 | 2019-2021 | |
| Asd Specialty Healthcare, LLC | $165.84 | 2023-2025 | |
| Tersera Therapeutics LLC | $158.01 | 2021-2025 | Zoladex, Xermelo |
| Servier Pharmaceuticals LLC | $154.52 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $148.80 | 2020-2023 | Givlaari, Onpattro |
| Janssen Scientific Affairs, LLC | $144.28 | 2019-2025 | Erleada, Akeega, Balversa |
| Emmaus Medical, INC. | $141.26 | 2021-2023 | Endari |
| Sun Pharmaceutical Industries INC. | $139.23 | 2022-2025 | |
| Genmab U.S., INC. | $126.74 | 2024-2025 | Epkinly |
| Mylan Institutional INC. | $119.65 | 2019-2023 | Fulphila, Ogivri |
| G1 Therapeutics, INC. | $119.44 | 2021-2023 | Cosela |
| Agios Pharmaceuticals, INC. | $119.20 | 2019-2025 | Pyrukynd |
| Beone Medicines USA, INC. | $112.74 | 2025 | Brukinsa, Tevimbra |
| Kite Pharma, INC. | $111.18 | 2020-2025 | Yescarta |
| Janssen Pharmaceuticals, INC | $108.14 | 2019-2020 | |
| Geron Corporation | $105.14 | 2025 | Rytelo |
| Azurity Pharmaceuticals, INC. | $88.15 | 2024-2025 | Danziten, Vivimusta |
| Kyowa Kirin, INC. | $82.13 | 2019-2025 | |
| Adc Therapeutics America, INC. | $79.33 | 2022-2025 | |
| Blue Earth Diagnostics | $75.94 | 2019-2021 | |
| Eagle Pharmaceuticals, INC. | $74.99 | 2023 | |
| Clovis Oncology, INC. | $72.02 | 2019-2022 | |
| Caris Mpi, INC. | $67.46 | 2025 | Mi Cancer Seek |
| Tesaro, INC. | $62.56 | 2019 | |
| Mirati Therapeutics, INC. | $61.99 | 2023-2024 | Krazati |
| Accord Healthcare, INC. | $60.89 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $51.88 | 2023-2024 | Orgovyx |
| Global Blood Therapeutics, INC. | $51.48 | 2020-2022 | |
| Myovant Sciences INC. | $49.86 | 2021-2022 | |
| Epizyme, INC. | $48.19 | 2020-2022 | |
| Foundation Medicine, INC. | $43.52 | 2019-2023 | |
| Springworks Therapeutics, INC. | $41.02 | 2024-2025 | Ogsiveo |
| Syndax Pharmaceuticals, INC. | $40.81 | 2025 | |
| Cti Biopharma Corp. | $39.36 | 2022-2023 | Vonjo |
| Spectrum Pharmaceuticals INC. | $33.37 | 2019-2023 | Rolvedon |
| Secura Bio, INC. | $32.87 | 2019 | |
| Celltrion USA INC. | $31.66 | 2023 | Vegzelma |
| Myriad Genetic Laboratories, INC. | $31.65 | 2023-2025 | Myrisk, Precisetumor |
| Aurobindo Pharma USA, INC. | $29.37 | 2019-2020 | |
| Btg International INC. | $28.75 | 2019-2020 | |
| Novo Nordisk INC | $28.66 | 2022-2023 | Novoeight, Rebinyn, Novoseven |
| Fortovia Therapeutics, INC. | $28.58 | 2019-2020 | |
| Shorla Oncology INC. | $25.31 | 2025 | |
| Adaptive Biotechnologies Corporation | $20.87 | 2025 | Clonoseq |
| Iovance Biotherapeutics, INC. | $20.10 | 2025 | Amtagvi |
| Mayne Pharma Commercial LLC | $19.97 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.28 | 2024 | Avastin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.84 | 2019 | |
| Fresenius Kabi USA, LLC | $17.76 | 2024 | Stimufend |
Drugs and devices associated with these payments
Kisqali $2,035Brukinsa $901Libtayo $845Keytruda $843Lenvima $637Venclexta $512Carvykti $470Calquence $401Erleada $398Lynparza $387Darzalex $332Jakafi $325Ojjaara $324Enhertu $316Tecentriq $305Xtandi $301Xospata $285Sarclisa $281Tecvayli $281Polivy $263Akeega $257Alecensa $234Epkinly $233Rybrevant $232Zepzelca $231Udenyca $228Verzenio $218Tukysa $218Besremi $213Fruzaqla $210Padcev $210Braftovi $205Empaveli $199Tagrisso $198Xt Cdx $196Onivyde $194Beleodaq $193Phesgo $192Mektovi $191Welireg $189Doptelet $186Fabhalta $184Imbruvica $183Scemblix $181Fotivda $180Orserdu $179Talzenna $172Qinlock $171Talvey $170Reblozyl $163Ayvakit $157Provenge $157Lunsumio $146Monoferric $143Injectafer $140Tavalisse $140Rezlidhia $140Jaypirca $140Ultomiris $138Orgovyx $135Somatuline Depot $130Imfinzi $128Stivarga $126Vitrakvi $126Balversa $125Xpovio $122Columvi $121Ibrance $120Lorbrena $118Nubeqa $117Jemperli $112Zejula $112Rytelo $105Tibsovo $103Itovebi $102Opdualag $99.24Zoladex $97.11Kadcyla $96.04Perjeta $96.04Imdelltra (Amg757) $92.33Inqovi $88.70Lonsurf $88.70Rozlytrek $84.26Cabometyx $84.14Pomalyst $82.53Elrexfio $81.51Trodelvy $79.03Bavencio $77.58Iclusig $77.15Vonjo $76.09Eliquis $75.49Pemfexy $74.99Jevtana $73.37Panzyga $71.39Adcetris $70.94Mi Cancer Seek $67.46Monjuvi $67.46Pemazyre $67.46Tazverik $65.60Tevimbra $64.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rizwan Danish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.